# US 2026/0078150 A1 · Mutated Glycoprotein of Vesicular Stomatitis Virus

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0078150 A1
- Document ID: US20260078150A1
- Status: Published application
- Kind: A1
- Application number: 19/320,938
- Filed: 2025-09-05
- Published: 2026-03-19
- Earliest claimed: 2017-09-22
- Assignees: Centre National de la Recherche Scientifique (CNRS); Universite Paris-Saclay
- Applicants: Centre National de la Recherche Scientifique (CNRS); Université Paris-Saclay
- Inventors: Aurélie Albertini; Yves Gaudin; Hèlène Raux; Laura Belot; Jovan Nikolic
- Web page: https://patentgrep.com/patent/US20260078150A1

## CPC

- C07K 14/005: from viruses
- C12N 7/00: Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00)
- C12N 2760/20222: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C12N 2760/20232: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
- C12N 2760/20245: Special targeting system for viral vectors
- C12N 2760/20262: by genetic engineering
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The invention relates to an isolated non-naturally occurring protein comprising the amino acid sequence as set forth in SEQ ID NO: 1, and wherein the amino acid in position 8, 47, 209 and/or 354 is substituted by any amino acid different from the amino acid indicated at that position in said sequence SEQ ID NO: 1.

## Claims

### Claim 1

A polypeptide comprising an amino acid sequence at least 95% identical to the amino acid sequence set forth in SEQ ID NO: 1, wherein the polypeptide comprises an amino acid substitution at position 47 and an amino acid substitution at position 354.

### Claim 2 (depends on 1)

The polypeptide of claim 1, wherein the polypeptide comprises an amino acid sequence at least 96% identical to the amino acid sequence set forth in SEQ ID NO: 1, wherein the polypeptide comprises an amino acid substitution at position 47 and an amino acid substitution at position 354.

### Claim 3 (depends on 1)

The polypeptide of claim 1, wherein the polypeptide comprises an amino acid sequence at least 97% identical to the amino acid sequence set forth in SEQ ID NO: 1, wherein the polypeptide comprises an amino acid substitution at position 47 and/or an amino acid substitution at position 354.

### Claim 4 (depends on 1)

The polypeptide of claim 1, wherein the polypeptide comprises an amino acid sequence at least 98% identical to the amino acid sequence set forth in SEQ ID NO: 1, wherein the polypeptide comprises an amino acid substitution at position 47 and/or an amino acid substitution at position 354.

### Claim 5 (depends on 1)

The polypeptide of claim 1, wherein the polypeptide comprises an amino acid sequence at least 99% identical to the amino acid sequence set forth in SEQ ID NO: 1, wherein the polypeptide comprises an amino acid substitution at position 47 and/or an amino acid substitution at position 354.

### Claim 6 (depends on 3, 4, 5)

The polypeptide of any one of claims 3 to 5, wherein the polypeptide comprises:
(a) an amino acid substitution at position 47 and position 354; or
(b) an amino acid substitution at position 47 or position 354.

### Claim 7 (depends on 1, 2, 3, 4, 5)

The polypeptide of any one of claims 1 to 5, wherein position 47 is substituted with any amino acid substitution except lysine or arginine.

### Claim 8 (depends on 1, 2, 3, 4, 5)

The polypeptide of any one of claims 1 to 5, wherein the polypeptide comprises an amino acid substitution at position 47 selected from the group consisting of: glycine, alanine, valine, leucine, isoleucine, threonine, serine, methionine, cysteine, proline, phenylalanine, tyrosine, tryptophan, histidine, aspartate, glutamate, asparagine, and glutamine.

### Claim 9 (depends on 1, 2, 3, 4, 5)

The polypeptide of any one of claims 1 to 5, wherein position 354 is substituted with any amino acid substitution except lysine or arginine.

### Claim 10 (depends on 1, 2, 3, 4, 5)

The polypeptide of any one of claims 1 to 5, wherein the polypeptide comprises an amino acid substitution at position 354 selected from the group consisting of: glycine, alanine, valine, leucine, isoleucine, threonine, serine, methionine, cysteine, proline, phenylalanine, tyrosine, tryptophan, histidine, aspartate, glutamate, asparagine, and glutamine.

### Claim 11 (depends on 1, 2, 3, 4, 5)

The polypeptide of any one of claims 1 to 5, wherein position 47 and position 354 are substituted with any amino acid substitution except lysine or arginine.

### Claim 12 (depends on 1, 2, 3, 4, 5)

The polypeptide of any one of claims 1 to 5, wherein the polypeptide comprises an amino acid substitution at position 47 and an amino acid substitution at position 354, wherein in each substituted amino acid is selected from the group consisting of: glycine, alanine, valine, leucine, isoleucine, threonine, serine, methionine, cysteine, proline, phenylalanine, tyrosine, tryptophan, histidine, aspartate, glutamate, asparagine, and glutamine.

### Claim 13 (depends on 1, 2, 3, 4, 5)

A nucleic acid molecule encoding the polypeptide of any one of claims 1 to 5.

### Claim 14 (depends on 1, 2, 3, 4, 5)

A recombinant virus expressing the polypeptide of any one of claims 1 to 5.

### Claim 15 (depends on 1, 2, 3, 4, 5)

A eukaryotic cell containing or expressing the polypeptide of any one of claims 1 to 5.

### Claim 16 (depends on 1, 2, 3, 4, 5)

A eukaryotic cell containing or expressing a polynucleotide encoding the polypeptide of any one of claims 1 to 5.

### Claim 17 (depends on 1, 2, 3, 4, 5)

A eukaryotic cell infected by a recombinant virus expressing the polypeptide of any one of claims 1 to 5.

### Claim 18 (depends on 1, 2, 3, 4, 5)

A composition comprising the polypeptide of any one of claims 1 to 5.

### Claim 19 (depends on 1, 2, 3, 4, 5)

A membrane comprising the polypeptide of any one of claims 1 to 5, wherein the polypeptide is anchored in the membrane, and wherein the membrane is the membrane of a liposome, vesicle, exosome, or nanoparticle.
